| Gastrointestinal Neoplasms |
PROCAPP, NCT01626781: A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer |
|
|
| No Longer Available | 3 | | Europe | Mapisal, Urea hand-foot cream | AIO-Studien-gGmbH | the Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast Cancer, Who Are Treated With Capecitabine | | | | |
| Active, not recruiting | 3 | 788 | Europe | cisplatin+capecitabine, radiotherapy, epirubicin+cisplatin+capecitabine | Dutch Colorectal Cancer Group, The Netherlands Cancer Institute, Roche Pharma AG | Gastric Cancer | 12/18 | 12/25 | | |
NCT02852915: Laparoscopic Surgery for T4 Tumor of the Colon Cancer |
|
|
| Not yet recruiting | 3 | 1960 | RoW | Laparoscopic surgery, Laparoscopic surgery for T4 colon cancers | LI XIN-XIANG | Colonic Neoplasms | 10/19 | 10/24 | | |
APREMEC, NCT02607072: Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized Trial |
|
|
| Recruiting | 3 | 3000 | RoW | Acetylsalicylic acid (ASA)/aspirin 200 mg daily, Acetylsalicylic acid (ASA)/aspirin 100 mg daily, Placebo | The Fourth Affiliated Hospital of Anhui Medical University, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital | Colorectal Cancer | 10/20 | 10/22 | | |
NCT02461043: Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma |
|
|
| Recruiting | 3 | 386 | RoW | paclitaxel; cisplatin, radiation | Chinese Academy of Medical Sciences | Esophageal Cancer | 12/20 | 12/23 | | |
NCT02635503: Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoid Cancer |
|
|
| Recruiting | 3 | 366 | RoW | transrectal specimen extraction, NOSE, Conventional laparoscopic surgery, CLS | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Colorectal Cancer | 12/20 | 12/25 | | |
ETAP, NCT02584985: Evaluate Efficacy, Morbidity and Functional Outcome of Endoscopic TranAnal Proctectomy vs Standard Transabdominal Laparoscopic Proctectomy for Rectal Cancer |
|
|
| Recruiting | 3 | 226 | Europe | ETAP, Standard Transabdominal Laparoscopic Proctectomy | Institut Paoli-Calmettes | Rectal Cancer | 01/21 | 01/24 | | |
APEC, NCT02965248: Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer ( Study) |
|
|
| Recruiting | 3 | 147 | RoW | Standard adjuvant systemic chemotherapy, adjuvant oxaliplatin, 5-FU, and leucovorin calcium (mFOLFOX6), adjuvant oxaliplatin and capecitabine (CapeOx), adjuvant 5-FU and leucovorin calcium (sLV5FU2), adjuvant capecitabine (Cape), Hyperthermic intraperitoneal chemotherapy (HIPEC) with raltitrexed, Intraperitoneal raltitrexed 3 mg/m2, Hyperthermic intraperitoneal chemotherapy (HIPEC) with oxaliplatin, I.V. leucovorin calcium 20 mg/m2, I.V. 5-FU 400 mg/m2, Intraperitoneal oxaliplatin 130 mg/m2 | Fudan University | Locally Advanced Colorectal Cancer | 11/21 | 11/23 | | |
RESCUE-GC, NCT02867839: Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer |
|
|
| Recruiting | 3 | 564 | RoW | Oxaliplatin plus S-1, SOX, S-1 only, S-1 | Peking University Cancer Hospital & Institute | Gastric Cancer | 02/22 | 02/24 | | |
NCT02715492: Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma. |
|
|
| Not yet recruiting | 3 | 40 | RoW | LMWH, Enoxaparin, TACE | Sherief Abd-Elsalam | HCC | 12/22 | 12/22 | | |
OLCMECC, NCT02682589: Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer |
|
|
| Recruiting | 3 | 1080 | RoW | Open surgery, Laparoscopic surgery | The First Affiliated Hospital with Nanjing Medical University, West China Hospital, Changhai Hospital, Chinese PLA General Hospital, Peking Union Medical College Hospital, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Wuhan Union Hospital, China, Fujian Medical University, First Affiliated Hospital of Chongqing Medical University | Colon Cancer | 04/23 | 04/23 | | |
PEPCORLI, NCT02912052: Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis |
|
|
| Not yet recruiting | 3 | 240 | RoW | Peri-operative chemotherapy, XELOX, postoperative chemotherapy | The First Affiliated Hospital with Nanjing Medical University | Colon Cancer | 10/23 | 10/23 | | |
SANO, NCT02705651: Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment |
|
|
| Not yet recruiting | 3 | 180 | NA | Somatostatin-Analog | Medical University of Vienna | Pancreatic Neuroendocrine Tumors in MEN1 | 10/23 | 10/24 | | |
NCT01815853: Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer |
|
|
| Recruiting | 3 | 620 | RoW | Neoadjuvant Chemoradiotherapy, Neoadjuvant Chemotherapy, R0 D2 Gastrectomy, Adjuvant Chemotherapy | Sun Yat-sen University, Guangdong Provincial People's Hospital, The First Affiliated Hospital of Anhui Medical University, Liaoning Cancer Hospital & Institute, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangxi Medical University Cancer Center, Tianjin Medical University Cancer Institute & Hospital, Zhejiang Cancer Hospital, First Hospital of China Medical University, First People's Hospital of Hangzhou | Gastric Cancer | 12/23 | 12/25 | | |
NCT02646137: Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma |
|
|
| Recruiting | 3 | 50 | RoW | Transarterial chemoembolization (TACE), Transarterial chemoembolization, Radiofrequency ablation combined with TACE, Microwave ablation combined with TACE | Sherief Abd-Elsalam, Tanta University | Liver Cancer | 12/23 | 12/23 | | |
| Not yet recruiting | 3 | 140 | Europe | Standard surgical treatment, Proactive management, Standard adjuvant systemic chemotherapy, adjuvant capecitabine and oxaliplatin (CAPOX), adjuvant 5-FU and oxaliplatin (FOLFOX) | University of Roma La Sapienza | Colon Cancer, Intraperitoneal Rectal Cancer | 09/24 | 09/25 | | |
| Active, not recruiting | 3 | 95000 | US, Europe, RoW | Colonoscopy | Oslo University Hospital, Maria Sklodowska-Curie National Research Institute of Oncology, Erasmus Medical Center, Landspitali University Hospital, Uppsala University Hospital, Karolinska Institutet, Memorial Sloan Kettering Cancer Center, Harvard School of Public Health (HSPH) | Colorectal Cancer | 06/26 | 07/36 | | |
| Not yet recruiting | 3 | 1800 | RoW | Aspirin, acetylsalicylic acid | Tel-Aviv Sourasky Medical Center, Rambam Health Care Campus, Rabin Medical Center, Soroka University Medical Center, Sheba Academic Medical Center Hospital | Lynch Syndrome I (Site-specific Colonic Cancer) | 09/27 | 09/27 | | |
| Recruiting | 2/3 | 584 | Europe | Carboplatin, Paclitaxel, Cisplatin, Capecitabine, Radiotherapy | Lisette Nixon, Cancer Research UK | Oesophageal Cancer | 04/21 | 04/23 | | |
PACHA-01, NCT02494973: Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases |
|
|
| Suspended | 2/3 | 104 | Europe | Oxaliplatin HAI, Oxaliplatin IV, mFOLFOX6, LV5FU2 | Gustave Roussy, Cancer Campus, Grand Paris, National Cancer Institute, France | Colorectal Cancer | 05/28 | 05/28 | | |
